new england journal of medicine semaglutide NEJM on X: "In an interim analysis a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full ESSENCE trial results The Science | ReMedical

Lindsay Testimonials It was excellent

Novo Nordisk filed for FDA approval of CagriSema in early 2026, with a review decision expected later this year

After taking a glutathione shot, you may experience bloating, cramping, or rashes

Mounjaro only FDA-approved for diabetes Wegovy FDA-approved for weight loss Insurance coverage by indication Why Zepbound may be better for weight loss Zepbound vs Ozempic Different Indications Weight loss medication vs diabetes medicationkey differences explained

Enhance cognitive function

While the exact mechanism isnt fully understood, it may relate to GLP-1s effects on fluid balance, autonomic nervous system regulation, or as a secondary consequence of other side effects like nausea or reduced fluid intake